Sodium butazolidine

• CAT Number: M071802
• CAS Number: 129-18-0
• Molecular Formula: C19H19N2NaO2
• Molecular Weight: 330.36
• Purity: ≥95%
• Storage: -20°C
• IUPAC Name: sodium;4-butyl-1,2-diphenylpyrazolidin-4-ide-3,5-dione
• InChI: InChI=1S/C19H19N2O2.Na/c1-2-3-14-17-18(22)20(15-10-6-4-7-11-15)21(19(17)23)16-12-8-5-9-13-16;/h4-13H,2-3,14H2,1H3;/q-1;+1
• InChIKey: VYOUHDLOIRJOSW-UHFFFAOYSA-N
• SMILES: CCCC[C-]1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3.[Na+]

Sodium butazolidine（Cat No.:M071802）, also known as sodium phenylbutazone, is a nonsteroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic properties. It belongs to the class of pyrazolone derivatives and is used primarily for the treatment of pain, inflammation, and fever associated with conditions such as arthritis and gout. Sodium butazolidine works by inhibiting the synthesis of prostaglandins, which are mediators of inflammation and pain. Despite its efficacy, its use has declined due to potential adverse effects such as gastrointestinal irritation, renal toxicity, and hematological disorders, prompting the development of safer NSAIDs.